Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Royal Bank Of Canada stock logo
RY
Royal Bank Of Canada
$129.61
-0.4%
$124.71
$102.89
$130.96
$182.97B0.891.15 million shs731,471 shs
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$91.46
-0.3%
$94.65
$89.22
$116.71
$18.10B0.721.81 million shs5.34 million shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Royal Bank Of Canada stock logo
RY
Royal Bank Of Canada
0.00%+1.91%+3.77%+15.68%+22.73%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.00%+0.27%-1.95%-18.49%-15.39%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Royal Bank Of Canada stock logo
RY
Royal Bank Of Canada
4.9439 of 5 stars
4.42.04.23.02.60.82.5
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
4.8471 of 5 stars
3.13.02.53.72.62.52.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Royal Bank Of Canada stock logo
RY
Royal Bank Of Canada
2.88
Moderate Buy$193.0048.91% Upside
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
2.29
Hold$111.5321.94% Upside

Current Analyst Ratings Breakdown

Latest ZBH and RY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/9/2025
Royal Bank Of Canada stock logo
RY
Royal Bank Of Canada
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
5/30/2025
Royal Bank Of Canada stock logo
RY
Royal Bank Of Canada
National Bank Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Sector Perform
5/20/2025
Royal Bank Of Canada stock logo
RY
Royal Bank Of Canada
CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
5/15/2025
Royal Bank Of Canada stock logo
RY
Royal Bank Of Canada
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSector Outperform
5/12/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$115.00 ➝ $101.00
5/7/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$140.00 ➝ $125.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$101.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$138.00 ➝ $115.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$120.00 ➝ $104.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$119.00 ➝ $104.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$125.00 ➝ $112.00
(Data available from 6/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Royal Bank Of Canada stock logo
RY
Royal Bank Of Canada
$98.71B1.85$10.42 per share12.44$60.95 per share2.13
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$7.68B2.36$13.20 per share6.93$62.67 per share1.46
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Royal Bank Of Canada stock logo
RY
Royal Bank Of Canada
$11.92B$9.0014.4012.831.4913.37%15.75%0.87%8/27/2025 (Estimated)
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$903.70M$4.5220.2310.312.1111.86%12.73%7.34%8/6/2025 (Estimated)

Latest ZBH and RY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/29/2025Q2 2025
Royal Bank Of Canada stock logo
RY
Royal Bank Of Canada
$2.25$2.20-$0.05$2.12$15.77 billion$11.38 billion
5/5/2025Q1 2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.77$1.81+$0.04$0.91$1.89 billion$1.91 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Royal Bank Of Canada stock logo
RY
Royal Bank Of Canada
$4.113.17%N/A45.67%15 Years
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$0.961.05%N/A21.24%N/A

Latest ZBH and RY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/30/2025
Royal Bank Of Canada stock logo
RY
Royal Bank Of Canada
quarterly$1.11523.3%7/24/20257/24/20258/22/2025
5/30/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
quarterly$0.241.03%6/26/20256/26/20257/31/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Royal Bank Of Canada stock logo
RY
Royal Bank Of Canada
0.11
0.82
0.82
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.53
2.44
1.46

Institutional Ownership

CompanyInstitutional Ownership
Royal Bank Of Canada stock logo
RY
Royal Bank Of Canada
45.31%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
88.89%

Insider Ownership

CompanyInsider Ownership
Royal Bank Of Canada stock logo
RY
Royal Bank Of Canada
N/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
1.39%
CompanyEmployeesShares OutstandingFree FloatOptionable
Royal Bank Of Canada stock logo
RY
Royal Bank Of Canada
94,8381.41 billionN/AOptionable
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
17,000197.85 million195.10 millionOptionable

Recent News About These Companies

ZBH - Zimmer Biomet Holdings Inc Executives | Morningstar
ZBH - Zimmer Biomet Holdings Inc Executives | Morningstar
Q2 EPS Estimates for Zimmer Biomet Lowered by Zacks Research
ZBH - Zimmer Biomet Holdings Inc Dividends | Morningstar
ZBH Zimmer Biomet Holdings, Inc. - Seeking Alpha

New MarketBeat Followers Over Time

Media Sentiment Over Time

Royal Bank Of Canada stock logo

Royal Bank Of Canada NYSE:RY

$129.61 -0.56 (-0.43%)
Closing price 06/27/2025 03:59 PM Eastern
Extended Trading
$129.68 +0.07 (+0.06%)
As of 06/27/2025 06:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Royal Bank of Canada operates as a diversified financial service company worldwide. The company's Personal & Commercial Banking segment offers checking and savings accounts, home equity financing, personal lending, private banking, indirect lending, including auto financing, mutual funds and self-directed brokerage accounts, guaranteed investment certificates, credit cards, and payment products and solutions; and lending, leasing, deposit, investment, foreign exchange, cash management, auto dealer financing, trade products, and services to small and medium-sized commercial businesses. This segment offers financial products and services through branches, automated teller machines, and mobile sales network. Its Wealth Management segment provides a suite of wealth, investment, trust, banking, credit, and other advice-based solutions and strategies to high net worth and ultra-high net worth individuals, and institutional clients; asset management products to institutional and individual clients; and asset and investor services to financial institutions, asset managers, and asset owners. The company's Insurance segment offers life, health, home, auto, travel, wealth, annuities, property and casualty, and reinsurance advice and solutions; and business insurance services to individual, business, and group clients through its advice centers, RBC insurance stores, and mobile advisors; digital platforms; and independent brokers and partners. The company's Capital Markets segment offers advisory and origination, sales and trading, lending and financing, and transaction banking services to corporations, institutional clients, asset managers, private equity firms, and governments. The company was founded in 1864 and is headquartered in Toronto, Canada.

Zimmer Biomet stock logo

Zimmer Biomet NYSE:ZBH

$91.46 -0.28 (-0.31%)
Closing price 06/27/2025 03:59 PM Eastern
Extended Trading
$91.84 +0.39 (+0.42%)
As of 06/27/2025 06:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.